Microbiology and minimum inhibitory concentration testing for Mycobacterium avium complex prophylaxis

American Journal of Medicine

Volumn 102, Issue 5 C, 1997, Pages 2-10

  Inderlied, Clark B ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; RIFABUTIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MICROBIOLOGY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; RADIOMETRY; SEROLOGY;

EID: 0030743379     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)00037-5     Document Type: Article

References (69)

1. Wayne LG, Good RC, Krichevsky MI, et al. Fourth report of the cooperative, open-ended study of slowly growing mycobacteria by the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol. 41:1991;463-472.
2. Soini H, Eerola E, Viljanen MK. Genetic diversity among Mycobacterium avium complex AccuProbe-positive isolates. J Clin Microbiol. 34:1996;55-57.
3. Wayne LG, Sramek HA. Agents of newly recognized or infrequently encountered mycobacterial diseases. Clin Microbiol Rev. 5:1992;1-25.
4. Rivoire B, Ranchoff BJ, Chatterjee D, et al. Generation of monoclonal antibodies to the specific sugar epitopes of Mycobacterium avium complex serovars. Infect Immunity. 57:1989;3147-3158.
5. Chin DP, Hopewell PC, Yajko DM, et al. Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk of M. avium complex bacteremia in patients with human immunodeficiency virus infection. J Infect Dis. 169:1994;289-295.
6. Oldfield EC, Dickinson G, Chung R, et al. Once weekly azithromycin for the prevention of Mycobacterium avium complex (MAC) infection in AIDS patients. (Abstr. 90.) 3rd National Conference on Human Retroviruses and Related Infections, Washington, DC, 1996.
7. Yajko DM, Nassos PS, Sanders CA, et al. Comparison of four decontamination methods for recovery of Mycobacterium avium complex from stools. J Clin Microbiol. 31:1993;302-306.
8. Horsburgh CR Jr, Chin DP, Yajko DM, et al. Environmental risk factors for acquisition of Mycobacterium avium complex in persons with human immunodeficiency virus infection. J Infect Dis. 170:1994;362-367.
9. von Reyn CF, Maslow JN, Barber TW, Falkinham J III, Arbeit RD. Persistent colonisation of potable water as a source of Mycobacterium avium infection in AIDS. (Comments). Lancet. 343:1994;1137-1141.
10. von Reyn CF, Pestel M, Arbeit RD. Clinical and epidemiologic implications of polyclonal infection due to Mycobacterium avium complex. Res Microbiol. 147:1996;24-30.
11. von Reyn CF, Waddell RD, Eaton T, et al. Isolation of Mycobacterium avium complex from water in the United States, Finland, Zaire, and Kenya. J Clin Microbiol. 31:1993;3227-3230.
12. Ostroff SM, Spiegel RA, Feinberg J, Benson CA, Horsburgh C Jr. Preventing disseminated Mycobacterium avium complex disease in patients infected with human immunodeficiency virus. Clin Infect Dis. 21:1995;S72-S76.
13. von Reyn CF, Barber TW, Arbeit RD, et al. Evidence of previous infection with Mycobacterium avium-Mycobacterium intracellulare complex among healthy subjects: an international study of dominant mycobacterial skin test reactions. J Infect Dis. 168:1993;1553-1558.
14. Mallal SA, James IR, French MA. Detection of subclinical Mycobacterium avium intracellulare complex infection in immunodeficient HIV-infected patients treated with zidovudine. AIDS. 8:1994;1263-1269.
15. Emler S, Böttger EC, Broers B, Cassis I, Perrin L, Hirschel B. Growth-deficient mycobacteria in patients with AIDS: diagnosis by analysis of DNA amplified from blood or tissue. Clin Infect Dis. 20:1995;772-775.
16. Torriani F, Maslow JN, Kornbluth RP, et al. Analysis of Mycobacterium avium complex (MAC) isolates infecting multiple organs of AIDS patients using pulsed field gel electrophoresis (PFGE). (Abstr. I91.) 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995.
17. DATRI 007 Study Group. Mycobacterium avium complex (MAC) disease in HIV-infected patients is a uniform infection of bone marrow that does not correlate with the level of infection in blood. (Abstr. 7.) 2nd National Conference on Human Retroviruses and Related Infections, Washington, DC, 1995.
18. Havlir DV, Dube MP, Sattler FR, et al. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. N Engl J Med. 335:1996;392-398.
19. Pierce M, Crampton S, Henry D, et al. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. N Engl J Med. 335:1996;384-391.
20. Nightingale SD, Cameron DW, Gordin FM, et al. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med. 329:1993;828-833.
21. Böttger EC, Wallace R Jr. Lack of rifabutin resistance with prophylaxis for disseminated Mycobacterium avium complex. (Letter; Comments.). Lancet. 344:1994;1506-1507.
22. Inderlied CB, Nash KA. Microbiology and in vitro susceptibility testing. Benson CA, Korvick JA. Mycobacterium avium-Complex Infection: Progress in Research and Treatment. 1995;263-284 Maracel Dekker, New York.
23. Doern GV, Westerling JA. Optimum recovery of Mycobacterium avium complex from blood specimens of human immunodeficiency virus-positive patients by using small volumes of isolator concentrate inoculated into Bactec 12B bottles. (Comments). J Clin Microbiol. 32:1994;2576-2577.
24. Hanna BA, Walters SB, Bonk SJ, Tick LJ. Recovery of mycobacteria from blood in mycobacteria growth indicator tube and Löwenstein-Jensen slant after lysis-centrifugation. J Clin Microbiol. 33:1995;3315-3316.
25. Bergmann JS, Woods GL. Clinical evaluation of the Roche Amplicor PCR Mycobacterium tuberculosis test for detection of M. tuberculosis in respiratory specimens. J Clin Microbiol. 34:1996;1083-1085.
26. Ichiyama S, Iinuma Y, Tawada Y, et al. Evaluation of Gen-Probe Amplified Mycobacterium tuberculosis Direct Test and Roche PCR-microwell plate hybridization method (Amplicor Mycobacterium) for direct detection of mycobacteria. J Clin Microbiol. 34:1996;130-133.
27. Jost K Jr, Dunbar DF, Barth SS, Headley VL, Elliott LB. Identification of Mycobacterium tuberculosis and M. avium complex directly from smear-positive sputum specimens and Bactec 12B cultures by high-performance liquid chromatography with fluorescence detection and computer-driven pattern recognition models. J Clin Microbiol. 33:1995;1270-1277.
28. Hocknell P, Spadoro J, Tevere V, Williams A, Graziani A, MacGregor R. Evaluating M. avium-intracellulare bacteremic patients with a PCR-based blood test during the course of antibiotic therapy. (Abstr.U-90.) 95th General Meeting of the American Society for Microbiology, Washington, DC, 1995.
29. Inderlied CB, DATRI 007 Study Group. Blood PCR assay for the detection and monitoring of M. avium complex in patients with disseminated disease. (Abstr. 808.) 4th National Conference on Human Retroviruses and Opportunistic Infections, Washington, DC, 1997.
30. Wayne LG, Good RC, Böttger EC, et al. Semantide- and chemotaxonomy-based analyses of some problematic phenotypic clusters of slowly growing mycobacteria, a cooperative study of the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol. 46:1996;280-297.
31. Böttger EC, Teske A, Kirschner P, et al. Disseminated "Mycobacterium genavense" infection in patients with AIDS. Lancet. 340:1992;76-80.
32. Tortoli E, Piersimoni C, Bacosi D, et al. Isolation of the newly described species Mycobacterium celatum from AIDS patients. J Clin Microbiol. 33:1995;137-140.
33. Springer B, Tortoli E, Richter I, et al. Mycobacterium conspicuum sp. nov., a new species isolated from patients with disseminated infections. J Clin Microbiol. 33:1995;2805-2811.
34. Springer B, Kirschner P, Rost Meyer G, Schroder KH, Kroppenstedt RM, Böttger EC. Mycobacterium interjectum, a new species isolated from a patient with chronic lymphadenitis. J Clin Microbiol 1993;31:3083-3089. (Published erratum appears in J Clin Microbiol. 1994;32:1417.).
35. Springer B, Kirschner P, Rost Meyer G, Schroder KH, Kroppenstedt RM, Böttger EC. Mycobacterium interjectum, a new species isolated from a patient with chronic lymphadenitis. J Clin Microbiol 1993;31:3083-3089. (Published erratum appears in J Clin Microbiol. 1994;32:1417.).
36. Ahrens P, Giese SB, Klausen J, Inglis NF. Two markers, IS901-IS902 and p40, identified by PCR and by using monoclonal antibodies in Mycobacterium avium strains. J Clin Microbiol. 33:1995;1049-1053.
37. Frothingham R, Wilson KH. Sequence-based differentiation of strains in the Mycobacterium avium complex. J Bacteriol. 175:1993;2818-2825.
38. Guerrero C, Bernasconi C, Burki D, Bodmer T, Telenti A. A novel insertion element from Mycobacterium avium, IS1245, is a specific target for analysis of strain relatedness. J Clin Microbiol. 33:1995;304-307.
39. Nishimori K, Eguchi M, Nakaoka Y, Onodera Y, Ito T, Tanaka K. Distribution of IS901 in strains of Mycobacterium avium complex from swine by using IS901-detecting primers that discriminate between M. avium and Mycobacterium intracellulare. J Clin Microbiol. 33:1995;2102-2106.
40. Picardeau M, Vincent V. Typing of Mycobacterium avium isolates by PCR. J Clin Microbiol. 34:1996;389-392.
41. Slutsky AM, Arbeit RD, Barber W, et al. Polyclonal infections due to Mycobacterium avium complex in patients with AIDS detected by pulsed-field gel electrophoresis of sequential clinical isolates. J Clin Microbiol. 32:1994;1773-1778.
42. Nash KA, Inderlied CB. Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. Antimicrob Agents Chemother. 39:1995;2625-2630.
43. Mazurek GH, Hartman S, Zhang Y, et al. Large DNA restriction fragment polymorphism in the Mycobacterium avium-intracellulare complex: a potential epidemiologic tool. J Clin Microbiol. 31:1993;390-394.
44. Arbeit RD, Slutsky A, Barber TW, et al. Genetic diversity among strains of Mycobacterium avium causing monoclonal and polyclonal bacteremia in patients with AIDS. J Infect Dis. 167:1993;1384-1390.
45. von Reyn CF, Jacobs NJ, Arbeit RD, Maslow JN, Niemczyk S. Polyclonal Mycobacterium avium infections in patients with AIDS: variations in antimicrobial susceptibilities of different strains of M. avium isolated from the same patient. J Clin Microbiol. 33:1995;1008-1010.
46. Inderlied CB, Kemper CA, Bermudez LEM. The Mycobacterium avium complex. Clin Microbiol Rev. 6:1993;266-310.
47. Rastogi N, Barrow WW. Cell envelope constituents and the multifaceted nature of Mycobacterium avium pathogenicity and drug resistance. Res Microbiol. 45:1994;243-252.
48. Meier A, Heifets L, Wallace R Jr, et al. Molecular mechanisms of clarithromycin resistance in Mycobacterium avium: observation of multiple 23S rDNA mutations in a clonal population. J Infect Dis. 174:1996;354-360.
49. Meier A, Kirschner P, Springer B, et al. Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrob Agents Chemother. 38:1994;381-384.
50. Doucet-Populaire F, Truffot Pemot C, Grosset J, Jarlier V. Acquired resistance in Mycobacterium avium complex strains isolated from AIDS patients and beige mice during treatment with clarithromycin. J Antimicrob Chemother. 36:1995;129-136.
51. Carnbau E, Sougakoff W, Jarlier V. Amplification and nucleotide sequence of the quinolone resistance-determining region in the gyrA gene of mycobacteria. FEMS Microbiol Lett. 116:1994;49-54.
52. Guillemin I, Cambau E, Jarlier V. Sequences of conserved region in the A subunit of DNA gyrase from nine species of the genus Mycobacterium: phylogenetic analysis and implication for intrinsic susceptibility to quinolones. Antimicrob Agents Chemother. 39:1995;2145-2149.
53. Bermudez LE, Young LS, Inderlied CB. Rifabutin and sparfloxacin but not azithromycin inhibit binding of Mycobacterium avium complex to HT-29 intestinal mucosal cells. Antimicrob Agents Chemother. 38:1994;1200-1202.
54. Benson C. Disseminated Mycobacterium avium complex disease in patients with AIDS. AIDS Res Hum Retroviruses. 10:1994;913-916.
55. Benson CA. Treatment of disseminated Mycobacterium avium complex disease: a clinician's perspective. Res Microbiol. 147:1996;16-24.
56. Kemper CA, Havlir D, Haghighat D, et al. The individual microbiologic effect of three antimycobacterial agents, clofazimine, ethambutol, and rifampin, on Mycobacterium avium complex bacteremia in patients with AIDS. J Infect Dis. 170:1994;157-164.
57. Rastogi N, Goh KS, Bryskier A. Activities of roxithromycin used alone and in combination with ethambutol, rifampin, amikacin, ofloxacin, and clofazimine against Mycobacterium avium complex. Antimicrob Agents Chemother. 38:1994;1433-1438.
58. Bermudez LE, Nash KA, Petrofsky M, Young LS, Inderlied CB. Effect of ethambutol on emergence of clarithromycin-resistant Mycobacterium avium complex in the beige mouse model. J Infect Dis. 174:1996;1218-1222.
59. Inderlied CB, Nash KA. Antimycobacterial agents: in vitro susceptibility testing, spectra of activity, mechanisms of action and resistance, and assays for activity in biologic fluids. Lorian V. Antibiotics in Laboratory Medicine. 4th ed. 1996;127-175 Williams Williams & Wilkins, Baltimore, MD.
60. Inderlied CB, Salfinger M. Antimicrobial agents and susceptibility tests: mycobacteria. Murray PR. Manual of Clinical Microbiology. 6th ed. 1995;1385-1404 ASM Press, Washington, DC.
61. Siddiqi SH, Heifets LB, Cynamon MH, et al. Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolates. J Clin Microbiol. 31:1993;2332-2338.
62. Siddiqi SH. Radiometric (Bactec) tests for slowly growing mycobacteria. Isenberg HD. Clinical Microbiology Procedures Handbook. 514:1992;1-25 25, Washington, DC.
63. Heifets LB, Iseman MD. Choice of antimicrobial agents for M. avium disease based on quantitative tests of drug susceptibility. N Engl J Med. 323:1990;419-420.
64. Beaty S, Siddiqi S, Gnacek M. Increase of pH of 12B medium by various means and its effect on the growth of M. avium complex. (Abstr. U-102.) 92nd General Meeting of the American Society for Microbiology, New Orleans, LA, 1992.
65. Inderlied CB. Antimycobacterial susceptibility testing: present practices and future trends. Eur J Clin Microbiol Infect Dis. 13:1994;980-993.
66. Oh YK, Straubinger RM. Intracellular fate of Mycobacterium avium: use of dual-label spectrofluorometry to investigate the influence of bacterial viability and opsonization on phagosomal pH and phagosome-lysosome interaction. Infect Immun. 64:1996;319-325.
67. Rathman M, Sjaastad MD, Falkow S. Acidification of phagosomes containing Salmonella typhimurium in murine macrophages. Infect Immun. 64:1996;2765-2773.
68. Sturgill-Koszycki S, Schlesinger PH, Chakraborty P, et al. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science. 263:1994;678-681.
69. Nash KA, Inderlied CB. Rapid detection of mutations associated with macrolide resistance in Mycobacterium avium complex. Antimicrob Agents Chemother. 40:1996;1748-1750.